Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefano Panni
Real-World Efficacy and Safety of Nivolumab in Previously-Treated Metastatic Renal Cell Carcinoma, and Association Between Immune-Related Adverse Events and Survival: The Italian Expanded Access Program
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
New Developments in the Treatment of Chemotherapy-Induced Neutropenia: Focus on Balugrastim
Therapeutics and Clinical Risk Management
Related publications
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association With Outcomes
Clinical Cancer Research
Cancer Research
Oncology
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results From a Real‐World Population
Oncologist
Cancer Research
Medicine
Oncology
Real-World Treatment Patterns and Adverse Events in Metastatic Renal Cell Carcinoma From a Large US Claims Database
BMC Cancer
Cancer Research
Oncology
Genetics
MA10.06 Impact of Immune-Related Adverse Events on Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
1302pdifct-1502 CLINIVO: Real-Life Experience With Nivolumab in 600 Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC): Efficacy and Safety of Nivolumab and Post-Nivolumab Treatment in the French Expanded Access Program (EAP)
Annals of Oncology
Medicine
Oncology
Hematology
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Therapeutic Effects and Associated Adverse Events of Multikinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Pcn6 - Systematic Literature Review of Efficacy & Safety Data for the Treatment of Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental